Ardelyx (ARDX) Interest Expenses (2013 - 2026)
Ardelyx (ARDX) reported Interest Expenses of $5.6 million for Q1 2026, up 33.6% on a YoY basis from $4.2 million in Q1 2025, and down 2.78% quarter-over-quarter from $5.8 million in Q4 2025.
Ardelyx (ARDX) Interest Expenses (2013 - 2026) Analysis & Trends
Ardelyx has reported Interest Expenses for 11 years, with the latest figure at $5.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 33.6% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $21.5 million (up 44.94% YoY), and the FY2025 full-year result was $20.1 million, up 54.56% from the prior year.
- Interest Expenses for Q1 2026 stood at $5.6 million, down from $5.8 million in the prior quarter.
- The five-year high for Interest Expenses was $5.8 million in Q3 2025, with the low at $746000.0 in Q1 2022.
- Historically, Interest Expenses has averaged $2.8 million across 5 years, with a median of $2.4 million in 2024.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 35.36% — and 2024, when it surged 209.4%.
- Ardelyx's Interest Expenses stood at $991000.0 in 2022, then jumped by 75.58% to $1.7 million in 2023, then soared by 127.99% to $4.0 million in 2024, then soared by 45.17% to $5.8 million in 2025, then retreated by 2.78% to $5.6 million in 2026.
- The last three Interest Expenses figures came in at $5.6 million (Q1 2026), $5.8 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.60 Mn |
| Mar 31, 2026 | 5.60 Mn |
| Dec 31, 2025 | 5.76 Mn |
| Dec 31, 2025 | 5.76 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 3.97 Mn |
| Dec 31, 2024 | 3.97 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Dec 31, 2023 | 1.74 Mn |